Mast Cell Activation Syndrome Treatment Approach

Introduction to MCAS

• Weight change, including weight gain, is recognized as a nonspecific clinical manifestation in patients with mast cell activation syndrome (MCAS), but treatment should focus on managing the underlying mast cell activation rather than targeting weight specifically, as recommended by the American Academy of Allergy, Asthma, and Immunology 1

Primary Treatment Strategy

• H1 antihistamines serve as the foundation of treatment, with nonsedating second-generation agents preferred at standard doses that can be increased to 2-4 times the FDA-approved level for refractory symptoms, according to the American College of Allergy, Asthma, and Immunology 2
• H2 antihistamines should be added for gastrointestinal symptoms and may help H1 antihistamines attenuate cardiovascular manifestations, as suggested by the American Gastroenterological Association 2
• Combined H1 and H2 antihistamine therapy is effective when monotherapy fails to control symptoms, as recommended by the American College of Allergy, Asthma, and Immunology 2

Management of Comorbid Conditions

• Autonomic dysfunction (POTS) commonly coexists with MCAS and should be evaluated and managed independently, according to the American Autonomic Society 4
• Gastrointestinal dysmotility is more common in these patients and may require specific testing such as gastric emptying studies, as recommended by the American Gastroenterological Association 4
• Thyroid dysfunction (both hypothyroidism and hyperthyroidism) is listed among clinical manifestations that may occur alongside MCAS and requires separate evaluation, as suggested by the American Thyroid Association 1

Diagnosis and Referral

• The diagnosis of MCAS requires documentation of symptoms involving 2 or more organ systems with acute increases in mast cell mediator levels on 2 or more occasions, as recommended by the American Academy of Allergy, Asthma, and Immunology 1
• Referral to specialized centers with expertise in mast cell disorders or allergy specialists is strongly recommended when MCAS is suspected or confirmed, according to the National Comprehensive Cancer Network 5